These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15042193)

  • 1. Acute pancreatitis caused by meglumine antimoniate given for the treatment of visceral leishmaniasis.
    Lambertucci JR; França BM; Queiroz Ede M
    Rev Soc Bras Med Trop; 2004; 37(1):74-5. PubMed ID: 15042193
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis.
    de Lalla F; Pellizzer G; Gradoni L; Vespignani M; Franzetti M; Stecca C
    Clin Infect Dis; 1993 May; 16(5):730-1. PubMed ID: 8507769
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate.
    Kuyucu N; Kara C; Bakirtaç A; Teziç T
    Pediatr Infect Dis J; 2001 Apr; 20(4):455-7. PubMed ID: 11332679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute pancreatitis during treatment with meglumine antimoniate (Glucantime)].
    Barthet M; Brunet P; Bernard JC; Dussol B; Rodor F; Jouglard J; Berland Y; Sahel J
    Gastroenterol Clin Biol; 1994; 18(1):90-2. PubMed ID: 8187998
    [No Abstract]   [Full Text] [Related]  

  • 5. Meglumine antimoniate-induced pancreatitis.
    Torrús D; Massa B; Boix V; Portilla J; Pérez-Mateo M
    Am J Gastroenterol; 1996 Apr; 91(4):820-1. PubMed ID: 8677970
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of three chemotherapeutic schemes with meglumine antimoniate in the treatment of visceral leishmaniasis in the State of Pará, Brazil.
    Marsden PD
    Rev Inst Med Trop Sao Paulo; 1993; 35(6):589. PubMed ID: 7997767
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nephrotic syndrome and acute pancreatitis related to glucantime administration].
    Valencia ME; Laguna F; González Lahoz J
    An Med Interna; 2000 Jan; 17(1):54. PubMed ID: 10730416
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection].
    Santos J; Rivero A; Márquez M
    An Med Interna; 2000 Oct; 17(10):562-3. PubMed ID: 11109659
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe leucopenia during treatment of visceral leishmaniasis.
    Hiçsönmez G; Jama H; Ozsoylu S
    Trans R Soc Trop Med Hyg; 1988; 82(3):417. PubMed ID: 3232176
    [No Abstract]   [Full Text] [Related]  

  • 10. Pancreatitis associated with N-methyl-glucamine therapy in a dog with leishmaniasis.
    Aste G; Di Tommaso M; Steiner JM; Williams DA; Boari A
    Vet Res Commun; 2005 Aug; 29 Suppl 2():269-72. PubMed ID: 16244972
    [No Abstract]   [Full Text] [Related]  

  • 11. High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients.
    Delgado J; Macías J; Pineda JA; Corzo JE; González-Moreno MP; de la Rosa R; Sánchez-Quijano A; Leal M; Lissen E
    Am J Trop Med Hyg; 1999 Nov; 61(5):766-9. PubMed ID: 10586909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil.
    Oliveira AL; Brustoloni YM; Fernandes TD; Dorval ME; Cunha RV; Bóia MN
    Trop Doct; 2009 Jul; 39(3):180-2. PubMed ID: 19535762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pancreatitis during treatment of leishmaniasis with n-methylglucamine antimoniate in a subject infected with HIV].
    Trinchieri V; Ferone U; Monacelli M; Isceri L; Proietti F; Sorice F
    Riv Eur Sci Med Farmacol; 1996; 18(2):49-51. PubMed ID: 9213843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meglumine antimoniate, amiodarone and torsades de pointes: a case report.
    Segura I; García-Bolao I
    Resuscitation; 1999 Sep; 42(1):65-8. PubMed ID: 10524732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Meglumine antimoniate].
    Silva JB
    Rev Soc Bras Med Trop; 2001; 34(1):103-5. PubMed ID: 11340506
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group.
    Laguna F; López-Vélez R; Pulido F; Salas A; Torre-Cisneros J; Torres E; Medrano FJ; Sanz J; Picó G; Gómez-Rodrigo J; Pasquau J; Alvar J
    AIDS; 1999 Jun; 13(9):1063-9. PubMed ID: 10397536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Symptomatic hypokalemia caused by meglumine antimoniate].
    Bouvresse S; Matichard E; Mahé E; Marinho E; Soria A; Devillière M; Descamps V; Crickx B
    Ann Dermatol Venereol; 2007 Apr; 134(4 Pt 1):387-8. PubMed ID: 17483764
    [No Abstract]   [Full Text] [Related]  

  • 18. Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis.
    Gasser RA; Magill AJ; Oster CN; Franke ED; Grögl M; Berman JD
    Clin Infect Dis; 1994 Jan; 18(1):83-90. PubMed ID: 7519887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentavalent antimonial-induced torsade de pointes.
    Ortega-Carnicer J; Alcázar R; De la Torre M; Benezet J
    J Electrocardiol; 1997 Apr; 30(2):143-5. PubMed ID: 9141610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [N-methyl glucamine antimoniate or Glucantime].
    Rapp C; Simon F; Dordain ML
    Med Trop (Mars); 2000; 60(4):342-3. PubMed ID: 11436584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.